LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies
Gastric cancer (GC) is an exceedingly aggressive disease and ranks as the third leading cause of cancer-related deaths, which poses a huge health burden globally. Chemotherapy is commonly employed during the middle to advanced stages of cancer, although it faces frequent treatment failures attribute...
Saved in:
| Main Authors: | WeiChi Liu, WeiFa Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1552773/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid−lncRNA Crossroads: An Overview of Interactions Between Lipids and lncRNA
by: Andrea Bayona-Hernandez, et al.
Published: (2025-08-01) -
Identification of a LncRNA based CeRNA network signature to establish a prognostic model and explore potential therapeutic targets in gastric cancer
by: Yuanqing An, et al.
Published: (2025-07-01) -
Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers
by: Reem A. Assal, et al.
Published: (2025-04-01) -
LncRNA–Protein Interactions: A Key to Deciphering LncRNA Mechanisms
by: Zuoneng Wang, et al.
Published: (2025-06-01) -
LncRNA interactomes and co-methylation in breast cancer regulation
by: Elena A. Filippova, et al.
Published: (2025-05-01)